<DOC>
	<DOCNO>NCT02701634</DOCNO>
	<brief_summary>This study evaluate effect entospletinib best overall response rate adult chronic graft versus host disease ( cGVHD ) currently receive systemic corticosteroid first-line therapy cGVHD .</brief_summary>
	<brief_title>Efficacy Tolerability Entospletinib Combination With Systemic Corticosteroids First-Line Therapy Adults With Chronic Graft Versus Host Disease ( cGVHD )</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Key Willing able provide write informed consent Male nonpregnant , nonlactating , females Newly diagnose cGVHD define : At least 100 day receive allogeneic hematopoietic stem cell transplant AND Receiving new course systemic corticosteroid ( ≥ 0.5 mg/kg/day ) firstline cGVHD therapy least 1 day 21 day prior first dose ENTO/Placebo AND Moderate severe cGVHD assess NIH cGVHD Diagnosis Staging Criteria ( NCDSC ) least three organ system involve OR one organ system score 2 OR lung organ score = 1 Individuals undergone transplant hematologic malignancy require complete remission . Have either normal ECG one abnormalities consider clinically insignificant investigator consultation Sponsor Key Inability begin systemic corticosteroid therapy dose ≥ 0.5 mg/kg/day ( equivalent ) Uncontrolled infection within 4 week prior randomization History follow therapy posttransplant period : B cell deplete biologic agent CD19 CART cell base therapy BTK/SYK/JAK/PI3K inhibitor Phototherapyunless administer acute GVHD Treatment cGVHD antithymocyte globulin ( ATG ) , campath within 60 day screen visit unless use treatment acute GVHD Severe organ dysfunction manifest screening period : Requiring supplemental oxygen 2 L/min Uncontrolled arrhythmia heart failure Note : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chronic Graft Versus Host Disease ( cGVHD )</keyword>
	<keyword>newly diagnose cGVHD</keyword>
	<keyword>immune reconstitution</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>allogeneic stem cell transplantation</keyword>
	<keyword>SYK inhibitor</keyword>
</DOC>